Some studies suggested that RSK2 overexpression is correlated with basal-like breast cancer and higher histological grade, and RSK2 mRNA is associated with poor survival in breast cancer patients who had not received chemotherapy (Stratford et al., 2012; Zhao et al., 2016). This evidence concerns the gene RPS6KA3 and breast cancer.